Tag Archives: cannabinoids

October, 2018

December, 2017

  • 15 December

    GW Pharma Reacquires Full Rights to Develop and Commercialize Sativex in the US

    London, UK, 13 Dec 2017: GW Pharmaceuticals plc (Nasdaq: GWPH, “GW” or “the Company”), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform, today announces the termination of its previous license agreement with Otsuka Pharmaceutical Co., Ltd. in relation to Sativex®(nabiximols) in the U.S. …

June, 2017

December, 2016